🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the efficacy, safety and tolerability, pharmaco...
Status
Terminated
Location
Thrive Health - Beverly Hills
Start Date
2024-03-27
Trial ID
NCT06307613
Treatments Being Tested
This study is part of the ADAPT Forward platform study (NCT07294170). ADAPT...
Status
Recruiting
Location
Visionary Investigators Network
Start Date
2026-07-10
Trial ID
NCT07673627
Treatments Being Tested
The main purpose of this study is to look at how efgartigimod affects thyro...
Status
Recruiting
Location
Diabetes Associates Medical Group
Start Date
2026-06-10
Trial ID
NCT07570316
Treatments Being Tested
ADAPT Forward is a platform study with the aim to look at how safe differen...
Status
Recruiting
Location
Profound Research LLC - Carlsbad
Start Date
2025-12-19
Trial ID
NCT07294170
Treatments Being Tested
This study aims to evaluate the efficacy, safety and tolerability, pharmaco...
Status
Terminated
Location
American Institute of Research
Start Date
2024-03-28
Trial ID
NCT06307626
Treatments Being Tested
The POLARIS study is designed to evaluate how well efgartigimod PH20 SC may...
Status
Recruiting
Location
Center for Neurosciences
Start Date
2026-08-15
Trial ID
NCT07583641
Treatments Being Tested
The main purpose of this study is to measure the long-term safety and toler...
Status
Enrolling By Invitation
Location
Neuromuscular Clinical and Research Center - Neurology
Start Date
2023-09-12
Trial ID
NCT05979441
Treatments Being Tested
The main purpose of this study is to look at how efgartigimod affects thyro...
Status
Recruiting
Location
TLC Diabetes and Endocrinology Clinic
Start Date
2026-06-10
Trial ID
NCT07596849
Treatments Being Tested
The aim of this study is to compare the amount of efgartigimod in the blood...
Status
Recruiting
Location
Altasciences
Start Date
2026-06-19
Trial ID
NCT07782775
Treatments Being Tested